GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eviana Health Corp (XCNQ:EHC) » Definitions » Cyclically Adjusted PS Ratio

Eviana Health (XCNQ:EHC) Cyclically Adjusted PS Ratio : (As of Jun. 06, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Eviana Health Cyclically Adjusted PS Ratio?

Eviana Health does not have a history long enough to calculate Cyclically Adjusted Revenue per Share. Therefore GuruFocus does not calculate Cyclically Adjusted PS Ratio for this company.

Shiller PE for Stocks: The True Measure of Stock Valuation


Eviana Health Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Eviana Health's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eviana Health Cyclically Adjusted PS Ratio Chart

Eviana Health Annual Data
Trend Jun15 Jun16 Jun17 Jun18
Cyclically Adjusted PS Ratio
- - - -

Eviana Health Quarterly Data
Jun15 Mar16 Jun16 Sep16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Eviana Health's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Eviana Health's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eviana Health's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eviana Health's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Eviana Health's Cyclically Adjusted PS Ratio falls into.



Eviana Health Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Eviana Health does not have a history long enough to calculate Cyclically Adjusted Revenue per Share. Therefore GuruFocus does not calculate Cyclically Adjusted PS Ratio for this company.


Eviana Health  (XCNQ:EHC) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Eviana Health Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Eviana Health's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Eviana Health (XCNQ:EHC) Business Description

Traded in Other Exchanges
N/A
Address
5728 East Boulevard, Vancouver, BC, CAN, V6M 4M4
Eviana Health Corp produces and sells cannabinoid products from natural hemp strains of cannabis sativa for consumer health-care products, pharmaceuticals, nutraceuticals, and cosmeceuticals, as well as for topical creams and other health and wellness products.
Executives
Olivier Robert Francis Benloulou 10% Security Holder